mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |